Income Statement (TTM)
Reliq Health Technologies Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 3 | 5 | 7 | 9 | 10 | 12 | 15 |
| Change (%) | -1.27 | 1.46 | 36.34 | 96.25 | 61.09 | 44.19 | 28.31 | 21.80 | 18.99 | 17.96 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 5 | 6 |
| Change (%) | -11.88 | -7.41 | -22.93 | 55.52 | 38.70 | 48.13 | 68.38 | 26.10 | 24.40 | 12.95 | |
| % of Revenue | 89.76 | 80.11 | 73.10 | 41.32 | 32.75 | 28.20 | 28.97 | 38.01 | 39.35 | 41.14 | 39.39 |
| Gross Operating Profit | 0 | 0 | 0 | 1 | 2 | 3 | 5 | 5 | 6 | 7 | 9 |
| Change (%) | 91.72 | 37.20 | 197.41 | 124.93 | 71.99 | 42.64 | 11.98 | 19.16 | 15.49 | 21.46 | |
| % of Revenue | 10.24 | 19.89 | 26.90 | 58.68 | 67.25 | 71.80 | 71.03 | 61.99 | 60.65 | 58.86 | 60.61 |
| SG&A | 9 | 10 | 10 | 11 | 14 | 13 | 12 | 11 | 8 | 6 | 7 |
| Change (%) | 8.16 | 2.83 | 2.06 | 30.31 | -5.39 | -10.75 | -3.71 | -28.31 | -20.66 | 9.68 | |
| % of Revenue | 868.72 | 951.64 | 964.49 | 722.02 | 479.43 | 281.57 | 174.29 | 130.79 | 76.98 | 51.33 | 47.73 |
| R&D | 2 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 3 | 4 | 3 |
| Change (%) | -21.46 | -7.68 | 41.86 | -22.42 | -9.78 | 67.39 | 9.52 | 30.32 | 21.02 | -11.76 | |
| % of Revenue | 157.29 | 125.12 | 113.85 | 118.46 | 46.83 | 26.23 | 30.45 | 25.99 | 27.81 | 28.28 | 21.15 |
| OpEx | 12 | 12 | 12 | 13 | 16 | 16 | 16 | 17 | 15 | 15 | 16 |
| Change (%) | 1.22 | -0.90 | 5.95 | 24.17 | -3.17 | 0.66 | 6.45 | -9.80 | -0.30 | 5.74 | |
| % of Revenue | 1,144.20 | 1,173.00 | 1,145.73 | 890.41 | 563.37 | 338.65 | 236.42 | 196.14 | 145.26 | 121.71 | 109.10 |
| Operating Income | -11 | -11 | -11 | -12 | -13 | -11 | -9 | -8 | -5 | -3 | -1 |
| Change (%) | 1.46 | -1.12 | 3.05 | 15.05 | -17.04 | -17.57 | -9.58 | -42.66 | -42.93 | -50.56 | |
| % of Revenue | -1,044.20 | -1,073.00 | -1,045.73 | -790.41 | -463.37 | -238.65 | -136.42 | -96.14 | -45.26 | -21.71 | -9.10 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | 18.15 | -8.51 | -3.77 | 2.51 | 1.12 | 2.60 | -28.84 | -12.05 | -8.01 | -9.91 | |
| % of Revenue | -4.19 | -5.01 | -4.52 | -3.19 | -1.67 | -1.05 | -0.74 | -0.41 | -0.30 | -0.23 | -0.18 |
| Net Income | -11 | -11 | -11 | -12 | -13 | -11 | -9 | -8 | -4 | -2 | -0 |
| Change (%) | 2.19 | -0.76 | 4.19 | 14.42 | -15.62 | -17.21 | -13.23 | -50.02 | -51.03 | -77.12 | |
| % of Revenue | -1,041.44 | -1,077.87 | -1,054.31 | -805.69 | -469.74 | -246.05 | -141.28 | -95.55 | -39.20 | -16.13 | -3.13 |
Source: Capital IQ
